What Researchers Did
Researchers conducted a pilot study with eight divers to evaluate if intranasal surfactant and other medications could improve Eustachian tube function and reduce middle ear barotrauma during repetitive diving.
What They Found
The study found significant interaction effects for drug-by-test and drug-by-dive-by-test in sonotubometry testing. Eustachian tube opening pressure (ETOP) showed trends toward improvement post-dive in all treatment groups, with oxymetazoline showing a significant improvement (p = 0.04). However, other drug interventions did not significantly improve Eustachian tube function over chance when measured by the Nine-Step Inflation/Deflation Tympanometry Test.
What This Means for Canadian Patients
Canadian divers experiencing Eustachian tube dysfunction, a common issue in diving, might explore options like oxymetazoline for potential temporary relief of ear pressure issues. While surfactant did not show clear benefits in this pilot study, understanding these mechanisms is crucial for preventing middle ear barotrauma. Patients should always consult their physician before using any medications for diving-related issues.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This pilot study was limited by its small sample size of eight divers and the large variability observed in Eustachian tube function among participants.